$AIMJun 22, 2026, 12:45 PMAI processed
AIM (AIM) to Present at Webull Corporate Connect Webinar on June 24
AI Summary
AIM ImmunoTech (NYSE: AIM) will present in the Webull Corporate Connect Webinar on June 24, 2026; CEO Thomas Equels is scheduled to speak from 2:40–3:00 PM ET. The appearance gives AIM near-term retail visibility to Webull’s ~27 million registered users, but the announcement does not include any new clinical, financial, or regulatory data.
Positives
- Presentation scheduled for June 24, 2026 (2:40–3:00 PM ET) — a defined near-term catalyst
- CEO Thomas Equels will present, offering direct management access
- Potential retail visibility to Webull’s ~27 million registered users
Negatives
- Press release does not announce any new clinical, financial, or regulatory data
- Investor webinar format does not guarantee material disclosures
- No agenda or specific planned disclosures provided beyond the time slot